肝动脉化疗栓塞联合瘤内注射无水乙醇对中晚期肝癌的疗效分析

李学应 已出版文章查询
李学应
本平台内已出版文章查询
yjycLxy@21cn.com
1 杨廉泽 已出版文章查询
杨廉泽
本平台内已出版文章查询
1

+ 作者地址

1广东省阳春市人民医院超声科,广东,阳春,529600


0
  • 摘要
  • 参考文献
  • 相关文章
  • 统计
目的 评估肝动脉化疗栓塞(TACE)联合CT引导下经皮穿刺瘤内无水乙醇注射术(PEI)对中晚期肝癌的疗效.方法 74例经证实为原发性中晚期肝癌随机分成3组,其中35例采用TACE+PEI治疗(TACE+PEI组),22例单纯采用TACE治疗(TACE组),17例单纯采用PEI治疗(PEI组).动态监测肝功能、甲胎蛋白变化,CT或B超下瘤体大小变化,胃纳的变化以及腹部体征.结果 3组疗效存在明显差异,TACE+PEI组的显效率+有效率明显高于单纯TACE组和单纯PEI组,且不良反应发生率低于单纯TACE组和单纯PEI组.结论 TACE联合无水乙醇治疗中晚期肝癌,安全可行,较单独使用TACE或PEI治疗达到了更好的局部治疗效果,提高了患者生存质量,延长了存活时间.

[1] Tempia AA;Ksontini R;Moradpour D et al.Hepatocellular carcinoma:a multidisciplinary approach[J].Rev Med Suisse,2005,1(24):1621-1629.

[2] Ueno K;Miyazono N;Inoue H et al.Transcatheter arterial chemoembolization therapy using iodized oilfor patients with unresectable hepatocellular carcinoma:evaluation of three kinds of regimens and analysis of prognostic factors[J].Cancer,2000,88(07):1574-1581.

[3] Ebara M;Okabe S;Kita K;Sugiura N;Fukuda H;Yoshikawa M;Kondo F;Saisho H .Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation.[J].Journal of Hepatology: The Journal of the European Association for the Study of the Liver,2005(3):458-464.

[4] Varotti G;Ramacciato G;Ercolani G;Grazi GL;Vetrone G;Cescon M;Del Gaudio M;Ravaioli M;Ziparo V;Lauro A;Pinna A .Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients.[J].European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,2005(7):760-767.

[5] Kurokohchi K;Hosomi N;Yoshitake A et al.Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation[J].Oricol Rep,2006,16(05):1067-1070.

[6] Vallone P;Catalano O;Izzo F et al.Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm[J].Cardiovascular and Interventional Radiology,2006,29(04):544-551.

[7] Sato K;Lewandowski RJ;Bui JT et al.Treatment of unresectable primary and metastatic liver cancer with yttrium microspheres:assessment of hepatic arterial embolization[J].Cardiovascular and Interventional Radiology,2006,29(04):522-529.

[8] Ebara M;Ohto M;Sugiura N et al.Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma.Study of 95 patients[J].Journal of Gastroenterology and Hepatology,1990,5(06):616-626.

[9] Daniele B;De Sio I;Izzo F;Capuano G;Andreana A;Mazzanti R;Aiello A;Vallone P;Fiore F;Gaeta GB;Perrone F;Pignata S;Gallo C .Hepatic Resection and Percutaneous Ethanol Injection as Treatments of Small Hepatocellular Carcinoma: A Cancer of the Liver Italian Program (CLIP 08) Retrospective Case-Control Study.[J].Journal of clinical gastroenterology,2003(1):63-67.

[10] Masaki T;Morishita A;Kurokohchi K;Kuriyama S .Multidisciplinary treatment of patients with hepatocellular carcinoma.[J].Expert review of anticancer therapy,2006(10):1377-1384.



期刊热词
  • + 更多
  • 字体大小